Biosims Technologies Overview
- Year Founded
-
2010
- Status
-
Out of Business
- Employees
-
11
- Latest Deal Type
-
Liquidation
Biosims Technologies General Information
Description
Developer and manufacturer of high-performance analytical tools for life science industries. The company's Dynaxi detection platform, its software and kits allows extremely low amounts of targets in a sample to be monitored, at a level never reached so far on a chip device.
Contact Information
Website
www.biosims-technologies.comCorporate Office
- Seine biopolis II
- 75, Route de Lyons la forêt
- 76000 Rouen
- France
Corporate Office
- Seine biopolis II
- 75, Route de Lyons la forêt
- 76000 Rouen
- France
Biosims Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Bankruptcy: Liquidation | 27-Dec-2016 | Completed | Bankruptcy: Liquidation | |||
| 5. Early Stage VC | 01-Apr-2016 | Completed | Startup | |||
| 4. Early Stage VC | 22-May-2015 | Completed | Startup | |||
| 3. Seed Round | 12-Dec-2013 | Completed | Startup | |||
| 2. Debt - General | Completed | Startup | ||||
| 1. Grant | Completed | Startup |
Biosims Technologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series P2 | ||||||||
| Series P1 | ||||||||
| Ordinary | ||||||||
| Series P2 | ||||||||
| Series P2 | ||||||||
| Series P1 | 39,583 | $1.116636 | $26.8 | $26.8 | 1x | $26.8 | 35.52% | |
| Ordinary | 10,000 | $1.116636 | $11.17 | $11.17 | 1x | $11.17 | 8.97% |
Biosims Technologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Biosims Technologies Patents
Biosims Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3023792-A1 | Spot control | Inactive | 18-Nov-2014 | ||
| EP-2684044-A1 | Method for detection and quantification of target biomolecules | Inactive | 10-Mar-2011 | ||
| CA-2828431-A1 | Method for detection and quantification of target biomolecules | Inactive | 10-Mar-2011 | ||
| US-20120172249-A1 | Method for a highly sensitive detection and quantification of biomolecules using secondary ion mass spectrometry (sims) | Inactive | 15-Sep-2009 | ||
| CA-2774125-A1 | Improved method for a highly sensitive detection and quantification of biomolecules using secondary ion mass spectrometry (sims) | Inactive | 15-Sep-2009 | G01N33/6848 |
Biosims Technologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Biosims Technologies FAQs
-
When was Biosims Technologies founded?
Biosims Technologies was founded in 2010.
-
Where is Biosims Technologies headquartered?
Biosims Technologies is headquartered in Rouen, France.
-
What is the size of Biosims Technologies?
Biosims Technologies has 11 total employees.
-
What industry is Biosims Technologies in?
Biosims Technologies’s primary industry is Biotechnology.
-
Is Biosims Technologies a private or public company?
Biosims Technologies is a Private company.
-
What is Biosims Technologies’s current revenue?
The current revenue for Biosims Technologies is .
-
How much funding has Biosims Technologies raised over time?
Biosims Technologies has raised $1.92M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
